Drug Interactions between influenza virus vaccine, live and Pepto-Bismol
This report displays the potential drug interactions for the following 2 drugs:
- influenza virus vaccine, live
- Pepto-Bismol (bismuth subsalicylate)
Interactions between your drugs
bismuth subsalicylate influenza virus vaccine, live
Applies to: Pepto-Bismol (bismuth subsalicylate) and influenza virus vaccine, live
Vaccination with influenza virus vaccine, live is not recommended in children less than 18 years of age who are receiving bismuth subsalicylate therapy. The use of bismuth subsalicylate or related medications has been linked to a serious and potentially fatal condition called Reye's syndrome in children with certain viral infections such as influenza or chicken pox. Because influenza virus vaccine, live contains live (but weakened) virus, there is some concern that it can cause Reye's syndrome when used with bismuth subsalicylate. The immunizing doctor should be informed of current or recent therapy with bismuth subsalicylate so that appropriate measures and/or precautions can be taken, such as substituting influenza virus vaccine, live with a vaccine that contains inactivated virus. Never give bismuth subsalicylate to children or adolescents who have a fever without talking to a doctor, especially if they also have flu symptoms or chicken pox. It is important to tell the doctor about all other medications being used, including vitamins and herbs. Do not stop using any medications without first talking to the doctor.
Drug and food interactions
No alcohol/food interactions were found. However, this does not necessarily mean no interactions exist. Always consult your healthcare provider.
Therapeutic duplication warnings
No warnings were found for your selected drugs.
Therapeutic duplication warnings are only returned when drugs within the same group exceed the recommended therapeutic duplication maximum.
See also
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
Check Interactions
To view an interaction report containing 4 (or more) medications, please sign in or create an account.
Save Interactions List
Sign in to your account to save this drug interaction list.